Maya Isaila, MD, PhD

Senior Director, Global Medical Hematologic Indications Lead
UCB Pharma

Maya Isaila MD, PhD, Senior Director, Global Indication Lead Hematology working at UCB Pharma since 2020
The well-being of every single patient is important and it’s hard to see treatments failing. Though the path to innovative treatment options can present challenges, UCB and I are dedicated to addressing people’s quality of life, and their symptoms. Our rare disease experts continue to work towards a potential solution for adults living with rare diseases.

Presentation(s):

• PB0340 - Treatment by Line in Patients With Persistent and Chronic Immune Thrombocytopenia, A Real-World Point-In-Time Study

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM